Physician
Carolinas Pain Center PLLC
Carolinas Pain Center PLLC was paid $573K by Medicaid between Jan 2018 and Dec 2024, across 42 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 50% of everything it billed.
33Billing provider infoCAROLINAS PAIN CENTER PLLC
HUNTERSVILLE, NC 28078
HUNTERSVILLE, NC 28078
33aNPI1912292335assigned 06/14/2011
33bProvider typePain Medicine (Anesthesiology) Physician
28Total paid$573K
24GClaims46,748
24DCodes billed42
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pain Medicine (Anesthesiology) Physician providers in North Carolina
Rank by total paid#12 of 43
Median peer was paid$90K
This provider vs. median6.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 7,522 | $77K | |
| 2019 | 6,953 | $48K | |
| 2020 | 5,778 | $61K | |
| 2021 | 8,637 | $93K | |
| 2022 | 4,298 | $63K | |
| 2023 | 7,016 | $121K | |
| 2024incomplete | 6,544 | $110K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 50% | 9,424 | 8,015 | $286K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 28% | 4,591 | 3,682 | $158K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 14% | 3,910 | 2,966 | $81K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 3.5% | 385 | 289 | $20K |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | 3.3% | 384 | 357 | $19K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 80 | 58 | $3K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | <1% | 58 | 38 | $2K |
| 76942 | <1% | 19 | 13 | $2K | |
| 64483 | <1% | 13 | 12 | $1K | |
| 20611 | <1% | 17 | 14 | $811.21 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 688 | 529 | $165.06 |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 53 | 43 | $91.62 |
30 more codes
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 5,416 | $0.00 |
| G8509 | Pain assessment documented as positive using a standardized tool, follow-up plan not documented, reason not given | 0% | 1,341 | $0.00 |
| G8541 | Functional outcome assessment using a standardized tool not documented, reason not given | 0% | 2,683 | $0.00 |
| G8752 | Most recent systolic blood pressure < 140 mmhg | 0% | 249 | $0.00 |
| 4004F | 0% | 342 | $0.00 | |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 861 | $0.00 |
| 3078F | 0% | 185 | $0.00 | |
| G8484 | Influenza immunization was not administered, reason not given | 0% | 1,584 | $0.00 |
| 4040F | 0% | 191 | $0.00 | |
| G9899 | Screening, diagnostic, film, digital or digital breast tomosynthesis (3d) mammography results documented and reviewed | 0% | 447 | $0.00 |
| 1090F | 0% | 102 | $0.00 | |
| G9900 | Screening, diagnostic, film, digital or digital breast tomosynthesis (3d) mammography results were not documented and reviewed, reason not otherwise specified | 0% | 60 | $0.00 |
| G8399 | Patient with documented results of a central dual-energy x-ray absorptiometry (dxa) ever being performed | 0% | 17 | $0.00 |
| G8400 | Patient with central dual-energy x-ray absorptiometry (dxa) results not documented, reason not given | 0% | 12 | $0.00 |
| 1036F | 0% | 1,824 | $0.00 | |
| 3017F | 0% | 3,465 | $0.00 | |
| G8756 | No documentation of blood pressure measurement, reason not given | 0% | 859 | $0.00 |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | 0% | 1,544 | $0.00 |
| G8432 | Depression screening not documented, reason not given | 0% | 3,638 | $0.00 |
| G9717 | Documentation stating the patient has had a diagnosis of bipolar disorder | 0% | 523 | $0.00 |
| G8419 | Bmi documented outside normal parameters, no follow-up plan documented, no reason given | 0% | 513 | $0.00 |
| G8754 | Most recent diastolic blood pressure < 90 mmhg | 0% | 421 | $0.00 |
| G9902 | Patient screened for tobacco use and identified as a tobacco user | 0% | 271 | $0.00 |
| G8536 | No documentation of an elder maltreatment screen, reason not given | 0% | 52 | $0.00 |
| 3074F | 0% | 93 | $0.00 | |
| 1123F | 0% | 191 | $0.00 | |
| 1101F | 0% | 113 | $0.00 | |
| G9906 | Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy) | 0% | 84 | $0.00 |
| 3075F | 0% | 33 | $0.00 | |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSHAH, BINIT (PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Mana Medical, INC. | Columbus, OH | $404K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.